A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications
- 17 December 2022
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 18 (2) , 149-161
Abstract
RNA interference (RNAi) using small interfering RNA (siRNA) is a promising strategy to control many genetic disorders by targeting the mRNA of underlying genes and degrade it. However, the delivery...Keywords
This publication has 153 references indexed in Scilit:
- Dendrimers for siRNA DeliveryPharmaceuticals, 2013
- RNAi and small interfering RNAs in human disease therapeutic applicationsTrends in Biotechnology, 2010
- Targeted Delivery of siRNA to Hepatocytes and Hepatic Stellate Cells by BioconjugationBioconjugate Chemistry, 2010
- The role of HER2 in cancer therapy and targeted drug deliveryJournal of Controlled Release, 2010
- Nanoparticles evading the reticuloendothelial system: Role of the supported bilayerBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- Biological Barriers to Therapy with Antisense and siRNA OligonucleotidesMolecular Pharmaceutics, 2009
- Peptide-Functionalized Nanogels for Targeted siRNA DeliveryBioconjugate Chemistry, 2009
- Antibody-Mediated Targeting of siRNA via the Human Insulin Receptor Using Avidin−Biotin TechnologyMolecular Pharmaceutics, 2008
- T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized MiceCell, 2008
- Lung Delivery Studies Using siRNA Conjugated to TAT(48−60) and Penetratin Reveal Peptide Induced Reduction in Gene Expression and Induction of Innate ImmunityBioconjugate Chemistry, 2007